Wallace Capital Management Inc. Gsk PLC Transaction History

Wallace Capital Management Inc.

$685 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $26,491 - $30,095	-630 Reduced 0.44%	143,420 $6.22 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $61,069 - $72,469	-1,518 Reduced 1.04%	144,050 $6.44 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $347,237 - $404,663	-8,931 Reduced 5.78%	145,568 $6.42 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $147,945 - $164,612	-3,814 Reduced 2.41%	154,499 $5.9 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $14,096 - $16,003	386 Added 0.24%	158,313 $6.3 Million
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $31,254 - $36,489	-912 Reduced 0.57%	157,927 $5.95 Million
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $261,112 - $306,100	-7,664 Reduced 4.6%	158,839 $5.85 Million
Q3 2020 Nov 16, 2020	SELL	$38.11 - $42.99 $258,385 - $291,472	-6,780 Reduced 3.91%	166,503 $6.27 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $62,750 - $72,212	-1,657 Reduced 0.95%	173,283 $7.07 Million
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $40,912 - $61,525	-1,260 Reduced 0.72%	174,940 $6.63 Million
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $166,698 - $191,504	-3,969 Reduced 2.2%	176,200 $8.28 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $163,053 - $175,385	-4,030 Reduced 2.19%	180,169 $7.69 Million
Q2 2019 Aug 12, 2019	BUY	$39.4 - $42.7 $9,692 - $10,504	246 Added 0.13%	184,199 $7.37 Million
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $45,358 - $50,203	1,176 Added 0.64%	183,953 $7.69 Million
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $1.41 Million - $1.6 Million	-37,372 Reduced 16.98%	182,777 $6.98 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $50,840 - $54,600	-1,279 Reduced 0.58%	220,149 $8.84 Million
Q2 2018 Aug 13, 2018	BUY	$39.61 - $42.76 $248,235 - $267,976	6,267 Added 2.91%	221,428 $8.93 Million
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $1.14 Million - $1.26 Million	31,485 Added 17.14%	215,161 $8.41 Million
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $169,384 - $200,826	4,793 Added 2.68%	183,676 $6.52 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $567,147 - $597,489	14,380 Added 8.74%	178,883 $7.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	164,503	164,503 $7.09 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wallace Capital Management Inc. with notifications on news.

Account